A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
Pfizer
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Juno Therapeutics, a Subsidiary of Celgene
Oncternal Therapeutics, Inc
Celgene
Amgen
Nordic Nanovector
Takeda
miRagen Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc
Merck Sharp & Dohme LLC
Takeda
M.D. Anderson Cancer Center
Amgen Research (Munich) GmbH
National Institutes of Health Clinical Center (CC)
Barbara Ann Karmanos Cancer Institute
Alliance for Clinical Trials in Oncology
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH
Mayo Clinic
Alliance for Clinical Trials in Oncology
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH
Novartis
Baylor College of Medicine
Ariad Pharmaceuticals
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Mayo Clinic